Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-10

AUTHORS

Bernhard Erdlenbruch, Verena Jendrossek, Angela Gerriets, Friedrich Vetterlein, Hansjörg Eibl, Max Lakomek

ABSTRACT

The clinical use of alkylphosphocholines (APC) in cancer patients is restricted because of the high gastrointestinal toxicity and the need for oral administration. Therefore we evaluated the clinical pharmacology of erucylphosphocholine (ErPC), the first derivative of the APC family suitable for intravenous administration with strong antineoplastic activity, in vitro and in vivo in rats. The pharmacokinetic parameters after a single intravenous dose of 40 mg/kg were calculated using a two-compartment model: C(max) = 1.6 +/- 0.3 micromol/ml, T(1/2alpha) = 0.18 +/- 0.09 h, T(1/2beta) = 3.3 +/- 0.88 h, clearance = 9.7 +/- 1.2 ml/h, AUC = 2.5 +/- 0.3 micromol/ml per h and Vss = 40.4 +/- 7.9 ml. Biodistribution studies were performed after repeated ErPC administration at different doses. Intravenous injections of 20 mg/kg given at intervals of 48 h for up to 4 weeks were well tolerated. Neither clinical evaluation nor laboratory parameters (haematology and clinical chemistry) revealed toxic side effects. In contrast, higher doses of ErPC (40 mg/kg per 48 h) led to weight loss. After 2 and 4 weeks of therapy with 20 mg/kg per 48 h a high ErPC accumulation was found in the adrenal glands, small intestine and brain. The brain to serum concentration ratios averaged 2.1 after 2 weeks and 4.5 after 4 weeks. Significant leucocytosis and thrombocytosis were observed after 4 weeks of ErPC treatment. The findings suggest that ErPC is a suitable candidate for clinical trials. In particular, owing to the high accumulation in brain tissue, ErPC is a potential agent for chemotherapy against malignant brain tumours. More... »

PAGES

484-490

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002800051122

DOI

http://dx.doi.org/10.1007/s002800051122

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047462305

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10550569


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Biological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylcholine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Wistar", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Distribution", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsmedizin G\u00f6ttingen", 
          "id": "https://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Universit\u00e4tskinderklinik G\u00f6ttingen, Robert-Koch-Str. 40, D-37075 G\u00f6ttingen, Germany Tel.: +49-551-396210; Fax: +49-551-396231, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Erdlenbruch", 
        "givenName": "Bernhard", 
        "id": "sg:person.01135237223.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135237223.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsmedizin G\u00f6ttingen", 
          "id": "https://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Universit\u00e4tskinderklinik G\u00f6ttingen, Robert-Koch-Str. 40, D-37075 G\u00f6ttingen, Germany Tel.: +49-551-396210; Fax: +49-551-396231, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jendrossek", 
        "givenName": "Verena", 
        "id": "sg:person.01172222364.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172222364.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsmedizin G\u00f6ttingen", 
          "id": "https://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Universit\u00e4tskinderklinik G\u00f6ttingen, Robert-Koch-Str. 40, D-37075 G\u00f6ttingen, Germany Tel.: +49-551-396210; Fax: +49-551-396231, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gerriets", 
        "givenName": "Angela", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Zentrum Pharmakologie, Abteilung Neuropharmakologie, Universit\u00e4t G\u00f6ttingen, Robert-Koch-Str. 40, D-37075 G\u00f6ttingen, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vetterlein", 
        "givenName": "Friedrich", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Max Planck Institute for Biophysical Chemistry", 
          "id": "https://www.grid.ac/institutes/grid.418140.8", 
          "name": [
            "Max-Planck-Institut f\u00fcr Biophysikalische Chemie, Am Fa\u00dfberg, D-37077 G\u00f6ttingen, Germany, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eibl", 
        "givenName": "Hansj\u00f6rg", 
        "id": "sg:person.01105334622.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105334622.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsmedizin G\u00f6ttingen", 
          "id": "https://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Universit\u00e4tskinderklinik G\u00f6ttingen, Robert-Koch-Str. 40, D-37075 G\u00f6ttingen, Germany Tel.: +49-551-396210; Fax: +49-551-396231, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lakomek", 
        "givenName": "Max", 
        "id": "sg:person.01217061436.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217061436.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1159/000217364", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004020662"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000225809", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023266050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01686464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023477918", 
          "https://doi.org/10.1007/bf01686464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01686464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023477918", 
          "https://doi.org/10.1007/bf01686464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(78)90125-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028202320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(78)90125-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028202320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02535556", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029511128", 
          "https://doi.org/10.1007/bf02535556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(88)90336-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033699947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000216779", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035336269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0305-7372(90)90053-i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036687880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/08982109509039914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041804929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ijo.14.1.15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071510910"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-10", 
    "datePublishedReg": "1999-10-01", 
    "description": "The clinical use of alkylphosphocholines (APC) in cancer patients is restricted because of the high gastrointestinal toxicity and the need for oral administration. Therefore we evaluated the clinical pharmacology of erucylphosphocholine (ErPC), the first derivative of the APC family suitable for intravenous administration with strong antineoplastic activity, in vitro and in vivo in rats. The pharmacokinetic parameters after a single intravenous dose of 40 mg/kg were calculated using a two-compartment model: C(max) = 1.6 +/- 0.3 micromol/ml, T(1/2alpha) = 0.18 +/- 0.09 h, T(1/2beta) = 3.3 +/- 0.88 h, clearance = 9.7 +/- 1.2 ml/h, AUC = 2.5 +/- 0.3 micromol/ml per h and Vss = 40.4 +/- 7.9 ml. Biodistribution studies were performed after repeated ErPC administration at different doses. Intravenous injections of 20 mg/kg given at intervals of 48 h for up to 4 weeks were well tolerated. Neither clinical evaluation nor laboratory parameters (haematology and clinical chemistry) revealed toxic side effects. In contrast, higher doses of ErPC (40 mg/kg per 48 h) led to weight loss. After 2 and 4 weeks of therapy with 20 mg/kg per 48 h a high ErPC accumulation was found in the adrenal glands, small intestine and brain. The brain to serum concentration ratios averaged 2.1 after 2 weeks and 4.5 after 4 weeks. Significant leucocytosis and thrombocytosis were observed after 4 weeks of ErPC treatment. The findings suggest that ErPC is a suitable candidate for clinical trials. In particular, owing to the high accumulation in brain tissue, ErPC is a potential agent for chemotherapy against malignant brain tumours.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s002800051122", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "name": "Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration", 
    "pagination": "484-490", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e2185393141d3161a34e8baa012e29f4d0ec216aa6129e7a3c4f26454b8b4c9f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10550569"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002800051122"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047462305"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002800051122", 
      "https://app.dimensions.ai/details/publication/pub.1047462305"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000515.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs002800051122"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002800051122'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002800051122'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002800051122'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002800051122'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      53 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002800051122 schema:about N181121f7bb604a868753005ab7579a1d
2 N2baa08b90f8148a3b0c80db8e06d471d
3 N34bce8a20e564cbfb669f57b23fdbc6b
4 N4bd5657883d04bc185a6448b468ed7a3
5 N510562372fa04686b1898caf7585d015
6 N826561ebbef845fd8c88811aee1680fc
7 N87ebc070aeef48ef96b731789ee04a52
8 Na0c7e3b74f91493195db732970a324dd
9 Nb17920cd327c40ed9d0497b6243f4b01
10 Nde2fe99af2604d84afd33761ae2b0671
11 Nde59319c19664a039eeb24bc08702b54
12 Nf1fa9210467243f19ad4b0a38997d18e
13 Nf449d54d7d3c4e85930d0531c14ac8f9
14 Nf5c6b0c5e44f4c87bd556dea7df0ccea
15 anzsrc-for:11
16 anzsrc-for:1115
17 schema:author N7311fc21e99f41c39db86c9f40e93772
18 schema:citation sg:pub.10.1007/bf01686464
19 sg:pub.10.1007/bf02535556
20 https://doi.org/10.1016/0005-2760(78)90125-x
21 https://doi.org/10.1016/0277-5379(88)90336-7
22 https://doi.org/10.1016/0305-7372(90)90053-i
23 https://doi.org/10.1159/000216779
24 https://doi.org/10.1159/000217364
25 https://doi.org/10.1159/000225809
26 https://doi.org/10.3109/08982109509039914
27 https://doi.org/10.3892/ijo.14.1.15
28 schema:datePublished 1999-10
29 schema:datePublishedReg 1999-10-01
30 schema:description The clinical use of alkylphosphocholines (APC) in cancer patients is restricted because of the high gastrointestinal toxicity and the need for oral administration. Therefore we evaluated the clinical pharmacology of erucylphosphocholine (ErPC), the first derivative of the APC family suitable for intravenous administration with strong antineoplastic activity, in vitro and in vivo in rats. The pharmacokinetic parameters after a single intravenous dose of 40 mg/kg were calculated using a two-compartment model: C(max) = 1.6 +/- 0.3 micromol/ml, T(1/2alpha) = 0.18 +/- 0.09 h, T(1/2beta) = 3.3 +/- 0.88 h, clearance = 9.7 +/- 1.2 ml/h, AUC = 2.5 +/- 0.3 micromol/ml per h and Vss = 40.4 +/- 7.9 ml. Biodistribution studies were performed after repeated ErPC administration at different doses. Intravenous injections of 20 mg/kg given at intervals of 48 h for up to 4 weeks were well tolerated. Neither clinical evaluation nor laboratory parameters (haematology and clinical chemistry) revealed toxic side effects. In contrast, higher doses of ErPC (40 mg/kg per 48 h) led to weight loss. After 2 and 4 weeks of therapy with 20 mg/kg per 48 h a high ErPC accumulation was found in the adrenal glands, small intestine and brain. The brain to serum concentration ratios averaged 2.1 after 2 weeks and 4.5 after 4 weeks. Significant leucocytosis and thrombocytosis were observed after 4 weeks of ErPC treatment. The findings suggest that ErPC is a suitable candidate for clinical trials. In particular, owing to the high accumulation in brain tissue, ErPC is a potential agent for chemotherapy against malignant brain tumours.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N5ddf88e2342f4ce69021191109a43cad
35 N5f67f40ddeb34b80858b882ca56e1281
36 sg:journal.1088364
37 schema:name Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration
38 schema:pagination 484-490
39 schema:productId N4d467438c7c5458eabd1b9fc98479b45
40 N6e1edfee29854ba3aedcb7db3d1f8850
41 Nda1da11bdbad433e85a72782904a4971
42 Ndde5996bfdb6412c81b2d02f69d0a289
43 Ne7d7b96c690b4695b0fd56b131234afe
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047462305
45 https://doi.org/10.1007/s002800051122
46 schema:sdDatePublished 2019-04-10T16:43
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N7836e2303caa40d5a453c1924de44003
49 schema:url http://link.springer.com/10.1007%2Fs002800051122
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N181121f7bb604a868753005ab7579a1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Injections, Intravenous
55 rdf:type schema:DefinedTerm
56 N2baa08b90f8148a3b0c80db8e06d471d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Animals
58 rdf:type schema:DefinedTerm
59 N32276ee3d8e248cea6a217602fa84b93 schema:affiliation N383fedea0fc441cab79ba409849bb593
60 schema:familyName Vetterlein
61 schema:givenName Friedrich
62 rdf:type schema:Person
63 N34bce8a20e564cbfb669f57b23fdbc6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Rats
65 rdf:type schema:DefinedTerm
66 N383fedea0fc441cab79ba409849bb593 schema:name Zentrum Pharmakologie, Abteilung Neuropharmakologie, Universität Göttingen, Robert-Koch-Str. 40, D-37075 Göttingen, Germany, DE
67 rdf:type schema:Organization
68 N3ece94ff2f8d4507b12c2ac3193be54d rdf:first N556bb34d39b44b998bb73eacaec053dc
69 rdf:rest N650b97290f8c4b05ab044f7a05bacbf2
70 N4bd5657883d04bc185a6448b468ed7a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Brain
72 rdf:type schema:DefinedTerm
73 N4d467438c7c5458eabd1b9fc98479b45 schema:name dimensions_id
74 schema:value pub.1047462305
75 rdf:type schema:PropertyValue
76 N510562372fa04686b1898caf7585d015 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Phosphorylcholine
78 rdf:type schema:DefinedTerm
79 N52b7adbb7ecf46c4b87b1ea8c6c69908 rdf:first sg:person.01105334622.36
80 rdf:rest N744281ca992542479c7998654c0dff7b
81 N556bb34d39b44b998bb73eacaec053dc schema:affiliation https://www.grid.ac/institutes/grid.411984.1
82 schema:familyName Gerriets
83 schema:givenName Angela
84 rdf:type schema:Person
85 N5ddf88e2342f4ce69021191109a43cad schema:issueNumber 6
86 rdf:type schema:PublicationIssue
87 N5f67f40ddeb34b80858b882ca56e1281 schema:volumeNumber 44
88 rdf:type schema:PublicationVolume
89 N650b97290f8c4b05ab044f7a05bacbf2 rdf:first N32276ee3d8e248cea6a217602fa84b93
90 rdf:rest N52b7adbb7ecf46c4b87b1ea8c6c69908
91 N6e1edfee29854ba3aedcb7db3d1f8850 schema:name readcube_id
92 schema:value e2185393141d3161a34e8baa012e29f4d0ec216aa6129e7a3c4f26454b8b4c9f
93 rdf:type schema:PropertyValue
94 N7311fc21e99f41c39db86c9f40e93772 rdf:first sg:person.01135237223.00
95 rdf:rest Na8ae8abb4d3b4e1abf4e9802621ff7ee
96 N744281ca992542479c7998654c0dff7b rdf:first sg:person.01217061436.17
97 rdf:rest rdf:nil
98 N7836e2303caa40d5a453c1924de44003 schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 N826561ebbef845fd8c88811aee1680fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Models, Biological
102 rdf:type schema:DefinedTerm
103 N87ebc070aeef48ef96b731789ee04a52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Rats, Wistar
105 rdf:type schema:DefinedTerm
106 Na0c7e3b74f91493195db732970a324dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Male
108 rdf:type schema:DefinedTerm
109 Na8ae8abb4d3b4e1abf4e9802621ff7ee rdf:first sg:person.01172222364.07
110 rdf:rest N3ece94ff2f8d4507b12c2ac3193be54d
111 Nb17920cd327c40ed9d0497b6243f4b01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Body Weight
113 rdf:type schema:DefinedTerm
114 Nda1da11bdbad433e85a72782904a4971 schema:name nlm_unique_id
115 schema:value 7806519
116 rdf:type schema:PropertyValue
117 Ndde5996bfdb6412c81b2d02f69d0a289 schema:name doi
118 schema:value 10.1007/s002800051122
119 rdf:type schema:PropertyValue
120 Nde2fe99af2604d84afd33761ae2b0671 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Metabolic Clearance Rate
122 rdf:type schema:DefinedTerm
123 Nde59319c19664a039eeb24bc08702b54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Blood Glucose
125 rdf:type schema:DefinedTerm
126 Ne7d7b96c690b4695b0fd56b131234afe schema:name pubmed_id
127 schema:value 10550569
128 rdf:type schema:PropertyValue
129 Nf1fa9210467243f19ad4b0a38997d18e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Leukocyte Count
131 rdf:type schema:DefinedTerm
132 Nf449d54d7d3c4e85930d0531c14ac8f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Antineoplastic Agents
134 rdf:type schema:DefinedTerm
135 Nf5c6b0c5e44f4c87bd556dea7df0ccea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Tissue Distribution
137 rdf:type schema:DefinedTerm
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
142 schema:name Pharmacology and Pharmaceutical Sciences
143 rdf:type schema:DefinedTerm
144 sg:journal.1088364 schema:issn 0344-5704
145 1432-0843
146 schema:name Cancer Chemotherapy and Pharmacology
147 rdf:type schema:Periodical
148 sg:person.01105334622.36 schema:affiliation https://www.grid.ac/institutes/grid.418140.8
149 schema:familyName Eibl
150 schema:givenName Hansjörg
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105334622.36
152 rdf:type schema:Person
153 sg:person.01135237223.00 schema:affiliation https://www.grid.ac/institutes/grid.411984.1
154 schema:familyName Erdlenbruch
155 schema:givenName Bernhard
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135237223.00
157 rdf:type schema:Person
158 sg:person.01172222364.07 schema:affiliation https://www.grid.ac/institutes/grid.411984.1
159 schema:familyName Jendrossek
160 schema:givenName Verena
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172222364.07
162 rdf:type schema:Person
163 sg:person.01217061436.17 schema:affiliation https://www.grid.ac/institutes/grid.411984.1
164 schema:familyName Lakomek
165 schema:givenName Max
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217061436.17
167 rdf:type schema:Person
168 sg:pub.10.1007/bf01686464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023477918
169 https://doi.org/10.1007/bf01686464
170 rdf:type schema:CreativeWork
171 sg:pub.10.1007/bf02535556 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029511128
172 https://doi.org/10.1007/bf02535556
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/0005-2760(78)90125-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028202320
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/0277-5379(88)90336-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033699947
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/0305-7372(90)90053-i schema:sameAs https://app.dimensions.ai/details/publication/pub.1036687880
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1159/000216779 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035336269
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1159/000217364 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004020662
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1159/000225809 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023266050
185 rdf:type schema:CreativeWork
186 https://doi.org/10.3109/08982109509039914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041804929
187 rdf:type schema:CreativeWork
188 https://doi.org/10.3892/ijo.14.1.15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071510910
189 rdf:type schema:CreativeWork
190 https://www.grid.ac/institutes/grid.411984.1 schema:alternateName Universitätsmedizin Göttingen
191 schema:name Universitätskinderklinik Göttingen, Robert-Koch-Str. 40, D-37075 Göttingen, Germany Tel.: +49-551-396210; Fax: +49-551-396231, DE
192 rdf:type schema:Organization
193 https://www.grid.ac/institutes/grid.418140.8 schema:alternateName Max Planck Institute for Biophysical Chemistry
194 schema:name Max-Planck-Institut für Biophysikalische Chemie, Am Faßberg, D-37077 Göttingen, Germany, DE
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...